John R. Regan - Concepedia

Author

John R. Regan

Boehringer Ingelheim (United States)

Also Known As

J. R. REGAN, J. R. Regan, J.R Regan, John R Regan, John R. Regan, John Regan

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Boehringer Ingelheim (United States)Boehringer Ingelheim (Japan)South College Boehringer Ingelheim (Germany)Boehringer Ingelheim (France)

About

John R. Regan is an author at Boehringer Ingelheim (United States) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.5K
2	Biochemistry	9	9	1.4K
3	Natural Sciences	8	8	580
4	Engineering	2	2	42
5	Biomolecular Engineering	2	2	42

John R. Regan

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site Christopher Pargellis, Liang Tong, Laurie Churchill, Nature Structural Biology Molecular PharmacologyDrug TargetMolecular PhysiologySignal TransductionBiochemistry	2002	832
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate John R. Regan, Steffen Breitfelder, Pier F. Cirillo, Journal of Medicinal Chemistry Drug TargetP38 Map KinaseAtp Binding SitePharmacotherapyChemical Biology	2002	349
The kinetics of binding to p38 MAP kinase by analogues of BIRB 796 John R. Regan, Christopher A. Pargellis, Pier F. Cirillo, Bioorganic & Medicinal Chemistry Letters	2003	111
Structure−Activity Relationships of the p38α MAP Kinase Inhibitor 1-(5-<i>tert</i>-Butyl-2-<i>p</i>-tolyl-2<i>H</i>-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)naph- thalen-1-yl]urea (BIRB 796) John R. Regan, Alison J. Capolino, Pier F. Cirillo, Journal of Medicinal Chemistry Drug TargetBirb 796Chemical BiologyPharmaceutical ChemistryMolecular Pharmacology	2003	105
Inhibitors of p38 mitogen-activated protein kinase for the treatment of rheumatoid arthritis. Christopher Pargellis, John R. Regan PubMed ImmunologyCell DeathP38 InhibitorsP38 Mitogen-activated ProteinOsteoporosis	2003	65
Thermal Denaturation: A Method to Rank Slow Binding, High-Affinity P38α MAP Kinase Inhibitors Rachel Kroe‐Barrett, John R. Regan, Al Proto, Journal of Medicinal Chemistry	2003	45
Quinol-4-ones as Steroid A-Ring Mimetics in Nonsteroidal Dissociated Glucocorticoid Agonists John R. Regan, Thomas Lee, Renée Zindell, Journal of Medicinal Chemistry ImmunologyGlucocorticoid AgonistsGlucocorticoidInflammationCell Signaling	2006	41
RG 12561 (Dalvastatin): A Novel Synthetic Inhibitor of HMG-CoA Reductase and Cholesterol-Lowering Agent Dilip Amin, Susan Gustafson, Judith M. Weinacht, Pharmacology Rg 12561Lipid PeroxidationCardiovascular PharmacologyPharmacotherapyRedox Biology	1993	35
Angiotensin converting enzyme inhibitors. 9. Novel [[N-(1-carboxyl-3-phenylpropyl)amino]acyl]glycine derivatives with diuretic activity J Barton, John J. Piwinski, Jerry W. Skiles, Journal of Medicinal Chemistry	1990	24
Synthesis of Functionalized Aromatic Oligomers from a Versatile Diphenylmethane Template Joseph G. Bruno, Ming‐Wen Chang, Yong Mi Choi-Sledeski, The Journal of Organic Chemistry Chemical EngineeringDiversity Oriented SynthesisEngineeringAlkene MetathesisBiochemistry	1997	22

Page 1